Compounds > 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Pregnancy

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Pregnancy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clapp, JF; Kett, A; Kim, H; Olariu, N; Soong, Y; Szeto, HH; Wu, D1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Pregnancy

ArticleYear
Respiratory depression after intravenous administration of delta-selective opioid peptide analogs.
    Peptides, 1999, Volume: 20, Issue:1

    Topics: Analgesics; Animals; Benzamides; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Female; Injections, Intravenous; Piperazines; Pregnancy; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiratory Physiological Phenomena; Sheep

1999